Brazil To Suspend Covaxin Deal As A "Preventive Measure" Amid Allegations Of Corruption Against Bolsonaro Govt
Brazil will reportedly suspend a $324 million contract for Bharat Biotech's Covaxin as a "preventive measure" amid a probe into accusations of alleged irregularities against President Jair Bolsonaro.
Bharat Biotech and Brazilian authorities have signed a $324 million contract for import of 20 million Covaxin doses in February this year.
Brazilian Health Minister Marcelo Queiroga while addressing a press conference on Tuesday (29 June) said that the ministry is going to carry out an administrative investigation to verify all aspects of the issue that are being raised.
"As soon as we have more concrete data, we will communicate," Queiroga said.
Meanwhile, the head of the Brazil's Federal Comptroller General (CGU) Wagner Rosario said that the agency will investigate the process of purchasing the vaccine.
"We suspended the deal as a simple preventive measure, since there are complaints that could not be explained well by the complainant, so we opened a preliminary investigation last week," said Rosario, as quoted by CNN Brasil.
"We have put in a reinforced team for the verification. We hope to be very quick in this process, and we hope that in no more than 10 days we will already have an answer for this analysis," Rosario added.
The negotiation between the Bolsonaro government and Need Medicines - the Brazilian pharmaceutical company that brokered the Covaxin deal - has been under the scanner, reports ANI.
President Bolsonaro is being accused of overlooking possible corruption in a deal to purchase coronavirus vaccines.
Bolsonaro, however, has slammed the senate probe into government's Covid-19 response, saying that it is aimed at undermining his administration.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.